KinDex Pharmaceuticals' Series A Round

KinDex Pharmaceuticals raised a round of funding on March 25, 2014. Investors include Polaris Partners.

KinDex was established in the fall of 2009 to focus on the discovery and development of molecules that modulate key regulatory networks associated with chronic disease. The principle targets for KinDe…

Articles about KinDex Pharmaceuticals' Series A Round: